Risk of Brain Metastasis in EGFR-Mutant NSCLC Treated With Erlotinib: A Role for Prophylactic Cranial Irradiation?: Metastatic Non-Small Cell Lung Cancer.

Authors :: Patel, S.
Rimner, A.
Foster, A.
Zhang, Z.
Woo, K.M.
Yu, H.A.
Riely, G.J.
Wu, A.J.
Source :: International Journal of Radiation Oncology, Biology, Physics. Nov2014 Supplement, Vol. 90 Issue 5, pS40-S41. 1p.
Publication Year :: 2014

Subjects :: *EPIDERMAL growth factor receptors
*BRAIN metastasis
*CANCER radiotherapy
*LUNG cancer treatment
*ERLOTINIB
*ANTINEOPLASTIC agents

Full Text Access

Tools